What Q32 Bio Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 4 |
| Sells | 6 | 11 |
| Total trades | 6 | 22 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 4,249,021 |
| Disposed | 22,054 | 70,338 |
| Net activity | −22,054 | +4,178,683 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Violette Shelia M. | Chief Scientific Officer | Oct 06 | Open-market sale · S | −917 | $8.32 | −$7.63K | 126,854 |
| Kalowski Lee | CFO and President | Oct 06 | Open-market sale · S | −1,301 | $8.32 | −$10.8K | 137,170 |
| Morrison Jodie Pope | CEO | Oct 06 | Open-market sale · S | −3,221 | $8.32 | −$26.8K | 340,038 |
| Kalowski Lee | CFO and President | Aug 25 | Open-market sale · S | −3,972 | $16.56 | −$65.8K | 138,471 |
| Violette Shelia M. | Chief Scientific Officer | Aug 25 | Open-market sale · S | −2,798 | $16.56 | −$46.3K | 127,771 |
| Morrison Jodie Pope | CEO | Aug 25 | Open-market sale · S | −9,845 | $16.56 | −$163K | 343,259 |
| Morrison Jodie Pope | CEO | Jul 16 | Grant / award · A | +132,000 | — | — | 353,104 |
| Kalowski Lee | CFO and President | Jul 16 | Grant / award · A | +53,250 | — | — | 142,443 |
| Violette Shelia M. | Chief Scientific Officer | Jul 16 | Grant / award · A | +37,500 | — | — | 130,569 |
| Manke Isaac | Director | Jun 30 | Exercise / conversion · M | +53,521 | $2.80 | +$150K | 53,521 |
| Xu Diyong | Director | May 28 | Open-market buy · P | +625,000 | $8.00 | +$5M | 625,000 |
| Xu Diyong | Director | May 28 | Open-market buy · P | +1,250,000 | $8.00 | +$10M | 3,502,987 |
| Orbimed Advisors Llc | Director | May 28 | Open-market buy · P | +625,000 | $8.00 | +$5M | 625,000 |
| Orbimed Advisors Llc | Director | May 28 | Open-market buy · P | +1,250,000 | $8.00 | +$10M | 3,502,987 |
| Violette Shelia M. | Chief Scientific Officer | Feb 25 | Open-market sale · S | −2,815 | $4.51 | −$12.7K | 55,569 |
| Morrison Jodie Pope | CEO | Feb 25 | Open-market sale · S | −9,896 | $4.51 | −$44.7K | 89,104 |
| Kalowski Lee | CFO and President | Feb 25 | Open-market sale · S | −3,995 | $4.51 | −$18K | 35,943 |
| Morrison Jodie Pope | CEO | Feb 24 | Grant / award · A | +132,000 | — | — | 221,104 |
| Violette Shelia M. | Chief Scientific Officer | Feb 24 | Grant / award · A | +37,500 | — | — | 93,069 |
| Kalowski Lee | CFO and President | Feb 24 | Grant / award · A | +53,250 | — | — | 89,193 |
Loading...
